Pairat, Yasser A.
HRN: 23-11-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
MUPIROCIN 2%, 15G (TUBE)
06/01/2023
06/07/2023
TOPICAL
NA
TID
INFECTED WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes